Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,729.04
(
0.44%
)
US TECH 100
24,203.60
(
0.78%
)
Dow Jones
47,136.12
(
0.40%
)
Brent Oil
99.19
(
0.90%
)
Bitcoin
74,452.89
(
-0.52%
)
News Focus
News Focus
Post# of 257251
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122790
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DragonBits post# 108521

Tuesday, 11/09/2010 11:39:27 AM

Tuesday, November 09, 2010 11:39:27 AM

Post# of 257251
The story has not been an easy one to follow; even some of the seasoned biotech investors and first-rate contributors on this board have been unwilling to believe that Teva has been routinely misrepresenting the status of its Lovenox ANDA to the investment community. If even these people have been reluctant to acknowledge what Teva is doing, it’s easy to understand how less-informed investors are not yet getting it either.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now